Factors Contributing Cost-Effectiveness for Treatment of Gastroesophageal Reflux Disease (GERD) and the Selection of Proton Pump Inhibitor (PPI) in Japan

被引:0
|
作者
Saitoh, Toshihito
Tonomura, Hideo
Otsuka, Kuniaki
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A488 / A488
页数:1
相关论文
共 50 条
  • [1] The impact of a formulary change in proton pump inhibitor(PPI)as maintenance treatment for gastroesophageal reflux disease(GERD).
    Schaberg, JW
    Chockalingam, SK
    Mah'moud, MA
    Moloo, J
    Ugheoke, EA
    Vasudeva, R
    GASTROENTEROLOGY, 1999, 116 (04) : A93 - A93
  • [2] Predictors for treatment failure of on-demand proton pump inhibitor (PPI) therapy in gastroesophageal reflux disease (GERD)
    Wu, Justin
    Cheung, Carnan
    Wong, Vincent
    Sung, Joseph
    GASTROENTEROLOGY, 2006, 130 (04) : A172 - A172
  • [3] Patient and Physician Perceptions on Dosing Directions for Proton Pump Inhibitor (PPI) in the Treatment of Gastroesophageal Reflux Disease (GERD)
    Solem, Caitlyn
    Mody, Reema
    Stephens, Jennifer
    Macahilig, Cynthia
    Carpiuc, Kim Tran
    Gao, Xin
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S411 - S411
  • [4] PREDICTORS OF PROTON PUMP INHIBITOR (PPI) DOSING REGIMEN AMONG PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE (GERD)
    Eisenberg, D.
    Mody, R.
    Singer, J.
    Kamat, S. A.
    Gerson, L. B.
    VALUE IN HEALTH, 2011, 14 (03) : A180 - A180
  • [5] Cost analysis of a new proposal for reimbursement of proton pump inhibitor treatment of gastroesophageal reflux disease (GERD) in Belgium
    Van Wilder, PB
    Arickx, F
    Vannecke, C
    Hiele, M
    Verpooten, GA
    VALUE IN HEALTH, 2003, 6 (06) : 685 - 686
  • [6] Cost-effectiveness of alginic acid in combination with proton pump inhibitor for the treatment of gastroesophageal reflux disease in systemic sclerosis patients
    Foocharoen, Chingching
    Kingkaew, Pritaporn
    Teerawattananon, Yot
    Mahakkanukrauh, Ajanee
    Suwannaroj, Siraphop
    Manasirisuk, Witsarut
    Chaiyarit, Jitjira
    Sangchan, Apichat
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (10) : 2037 - 2046
  • [7] COST-EFFECTIVENESS OF ALGINIC ACID IN COMBINATION WITH PROTON PUMP INHIBITOR FOR THE TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE IN SYSTEMIC SCLEROSIS PATIENTS
    Foocharoen, C.
    Kingkaew, P.
    Teerawattananon, Y.
    Mahakkanukrauh, A.
    Suwannaroj, S.
    Manasirisuk, W.
    Chaiyarit, J.
    Sangchan, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1678 - 1678
  • [8] COST-EFFECTIVENESS ANALYSIS OF PROTON PUMP INHIBITORS FOR TREATMENT OF SEVERE GASTROESOPHAGEAL REFLUX DISEASE IN MEXICO
    Pozo Urquizo, L.
    Latapi, E.
    Soto Molina, H.
    Polanco, A. C.
    VALUE IN HEALTH, 2012, 15 (04) : A139 - A139
  • [9] Evaluation of Proton-Pump-Inhibitor (PPI) -Resistant Gastroesophageal Reflux Disease (GERD) By Esophageal Motility Tests
    Kawaguchi, Shinpei
    Takeuchi, Toshihisa
    Takahashi, Yoshiaki
    Harada, Satoshi
    Ota, Kazuhiro
    Kojima, Yuichi
    Higuchi, Kazuhide
    GASTROINTESTINAL ENDOSCOPY, 2016, 83 (05) : AB586 - AB586
  • [10] Healthcare utilization and cost in pediatric gastroesophageal reflux disease (GERD) patients on continuous vs. intermittent proton pump inhibitor (PPI) treatment regimens
    Nelson, Suzanne P.
    Kothari, Smita
    Wu, Eric Q.
    Persson, Bjorn
    Beaulieu, Nicolas
    Arana, Mateo
    Lu, Mei
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S450 - S450